Cargando…
_version_ 1785090748637511680
author Tettero, Jesse
Palmieri, Raffaele
Lam Ngai, Lok
Bachas, Costa
Arena, Valentina
Breems, Dimitri
Fischer, Thomas
Tore Gjertsen, Bjorn
Griškevičius, Laimonas
Juliusson, Gunnar
Maertens, Johan
Manz, Markus
Maurillo, Luca
Pabst, Thomas
Passweg, Jakob
Piciocchi, Alfonso
Porkka, Kimmo
Löwenberg, Bob
Venditti, Adriano
Ossenkoppele, Gert
Buccisano, Francesco
Cloos, Jacqueline
author_facet Tettero, Jesse
Palmieri, Raffaele
Lam Ngai, Lok
Bachas, Costa
Arena, Valentina
Breems, Dimitri
Fischer, Thomas
Tore Gjertsen, Bjorn
Griškevičius, Laimonas
Juliusson, Gunnar
Maertens, Johan
Manz, Markus
Maurillo, Luca
Pabst, Thomas
Passweg, Jakob
Piciocchi, Alfonso
Porkka, Kimmo
Löwenberg, Bob
Venditti, Adriano
Ossenkoppele, Gert
Buccisano, Francesco
Cloos, Jacqueline
author_sort Tettero, Jesse
collection PubMed
description
format Online
Article
Text
id pubmed-10429573
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104295732023-08-17 P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL Tettero, Jesse Palmieri, Raffaele Lam Ngai, Lok Bachas, Costa Arena, Valentina Breems, Dimitri Fischer, Thomas Tore Gjertsen, Bjorn Griškevičius, Laimonas Juliusson, Gunnar Maertens, Johan Manz, Markus Maurillo, Luca Pabst, Thomas Passweg, Jakob Piciocchi, Alfonso Porkka, Kimmo Löwenberg, Bob Venditti, Adriano Ossenkoppele, Gert Buccisano, Francesco Cloos, Jacqueline Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429573/ http://dx.doi.org/10.1097/01.HS9.0000968636.18625.e3 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Tettero, Jesse
Palmieri, Raffaele
Lam Ngai, Lok
Bachas, Costa
Arena, Valentina
Breems, Dimitri
Fischer, Thomas
Tore Gjertsen, Bjorn
Griškevičius, Laimonas
Juliusson, Gunnar
Maertens, Johan
Manz, Markus
Maurillo, Luca
Pabst, Thomas
Passweg, Jakob
Piciocchi, Alfonso
Porkka, Kimmo
Löwenberg, Bob
Venditti, Adriano
Ossenkoppele, Gert
Buccisano, Francesco
Cloos, Jacqueline
P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL
title P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL
title_full P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL
title_fullStr P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL
title_full_unstemmed P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL
title_short P432: VALIDATION OF LIMIT OF QUANTIFICATION APPROACH BASED FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE ASSESSMENT IN ACUTE MYELOID LEUKEMIA IN THE HOVON-SAKK-132 TRIAL
title_sort p432: validation of limit of quantification approach based flow cytometry for measurable residual disease assessment in acute myeloid leukemia in the hovon-sakk-132 trial
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429573/
http://dx.doi.org/10.1097/01.HS9.0000968636.18625.e3
work_keys_str_mv AT tetterojesse p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT palmieriraffaele p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT lamngailok p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT bachascosta p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT arenavalentina p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT breemsdimitri p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT fischerthomas p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT toregjertsenbjorn p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT griskeviciuslaimonas p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT juliussongunnar p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT maertensjohan p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT manzmarkus p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT maurilloluca p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT pabstthomas p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT passwegjakob p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT piciocchialfonso p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT porkkakimmo p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT lowenbergbob p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT vendittiadriano p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT ossenkoppelegert p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT buccisanofrancesco p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial
AT cloosjacqueline p432validationoflimitofquantificationapproachbasedflowcytometryformeasurableresidualdiseaseassessmentinacutemyeloidleukemiainthehovonsakk132trial